| Autor: |
Yelena V. Grishina, Aleksey A. Vatlin, Dilara A. Mavletova, Maya V. Odorskaya, Alexey M. Senkovenko, Rustem A. Ilyasov, Valeriy N. Danilenko |
| Jazyk: |
angličtina |
| Rok vydání: |
2023 |
| Předmět: |
|
| Zdroj: |
BioTech, Vol 12, Iss 2, p 39 (2023) |
| Druh dokumentu: |
article |
| ISSN: |
2673-6284 |
| DOI: |
10.3390/biotech12020039 |
| Popis: |
Many kinds of Lactobacillus are common occupants of humans’ digestive tract that support the preservation of a balanced microbial environment that benefits host health. In this study, the unique lactic acid bacterium strain Limosilactobacillus fermentum U-21, which was isolated from the feces of a healthy human, was examined for its metabolite profile in order to compare it to that of the strain L. fermentum 279, which does not have antioxidant (AO) capabilities. By using GC × GC−MS, the metabolite fingerprint of each strain was identified, and the data were then subjected to multivariate bioinformatics analysis. The L. fermentum U-21 strain has previously been shown to possess distinctive antioxidant properties in in vivo and in vitro studies, positioning it as a drug candidate for the treatment of Parkinsonism. The production of multiple distinct compounds is shown by the metabolite analysis, demonstrating the unique characteristics of the L. fermentum U-21 strain. According to reports, some of the L. fermentum U-21 metabolites found in this study have health-promoting properties. The GC × GC−MS-based metabolomic tests defined strain L. fermentum U-21 as a potential postbiotic with significant antioxidant potential. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|
